Articles

Taking a breakthrough to the masses

ZyGEM acquires MicroLab Diagnostics to commercialize DNA testing, detection platform
| 3 min read

SOLANA BEACH, Calif.—ZyGEM has acquired MicroLab Diagnostics, a firm specializing in the development of microfluidic devices for rapid DNA testing.

ZyGEM intends to market products integrating its unique DNA extraction and reagents and detection assays with the breakthrough microfluidic chip technology developed by MicroLab, which will operate as a business unit of the new company.

Paul Kinnon, CEO of ZyGEM, says the acquisition will allow the company to combine the new microfluidic chip technology with its own DNA extraction and detection technologies.

"The aim is to develop assays for applications in fields ranging from point-of-care diagnostics and forensics to biodefense and food pathogen testing," Kinnon says.

MicroLab was founded in 2003 on technology developed by University of Virginia's Dr. James P. Landers, a professor of chemistry in the College of Arts & Sciences. It uses lab-on-a-chip technology to streamline the chemical processes involved in biochemical analysis, including DNA testing.

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

Here are some related topics that may interest you:

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Gloved hand holding a multiwell cell culture plate under a fluorescence microscope for spheroid analysis.
Using confocal live-cell imaging to characterize immune-mediated cytotoxicity over time.
Fluorescence microscopy image of cells displaying green and red fluorescent signals.
Using confocal live-cell imaging to assess treatment effects in spheroids, organoids, and co-cultures.
3D illustration of Y-shaped antibody molecules floating against a soft blue background, with a detailed antibody structure in the foreground.
From molecular developability to functional activity, integrated characterization strategies help inform lead selection and optimization in biologics discovery.